|
| [10] | K. Bettermann, M. Vucur, J. Haybaeck, C. Koppe, J. Janssen, F. Heymann, A. Weber, R. Weiskirchen, C. Liedtke, N. Gassler, M. Müller, R. de Vos, M. J. Wolf, Y. Boege, G. M. Seleznik, N. Zeller, D. Erny, T. Fuchs, S. Zoller, S. Cairo, M. Buendia, M. Prinz, S. Akira, F. Tacke, M. Heikenwalder, C. Trautwein, T. Luedde,
"TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer", Cancer Cell, vol. 17, no. 5, pp. 481–496.
|
| [9] | J. Gautheron, M. Vucur, F. Reisinger, D. V. Cardenas, C. Roderburg, C. Koppe, K. Kreggenwinkel, A. T. Schneider, M. Bartneck, U. P. Neumann, A. Canbay, H. L. Reeves, M. Luedde, F. Tacke, C. Trautwein, M. Heikenwalder, T. Luedde,
"A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis", EMBO Mol. Med., vol. 6, no. 8, pp. 1062–1074.
|
| [8] | J. Gautheron, M. Vucur, A. T. Schneider, I. Severi, C. Roderburg, S. Roy, M. Bartneck, P. Schrammen, M. B. Diaz, J. Ehling, F. Gremse, F. Heymann, C. Koppe, T. Lammers, F. Kiessling, N. Van Best, O. Pabst, G. Courtois, A. Linkermann, S. Krautwald, U. P. Neumann, F. Tacke, C. Trautwein, D. R. Green, T. Longerich, N. Frey, M. Luedde, M. Bluher, S. Herzig, M. Heikenwalder, T. Luedde,
"The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance", Nat. Commun., vol. 7, no. 1, pp. 11869.
|
| [7] | T. Luedde, U. Assmus, T. Wüstefeld, A. Meyer zu Vilsendorf, T. Roskams, M. Schmidt-Supprian, K. Rajewsky, D. A. Brenner, M. P. Manns, M. Pasparakis, C. Trautwein,
"Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury", J. Clin. Invest., vol. 115, no. 4, pp. 849–859.
|
| [6] | T. Luedde, N. Beraza, V. Kotsikoris, G. van Loo, A. Nenci, R. De Vos, T. Roskams, C. Trautwein, M. Pasparakis,
"Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma", Cancer Cell, vol. 11, no. 2, pp. 119–132.
|
| [5] | C. Roderburg, G. Urban, K. Bettermann, M. Vucur, H. Zimmermann, S. Schmidt, J. Janssen, C. Koppe, P. Knolle, M. Castoldi, F. Tacke, C. Trautwein, T. Luedde,
"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis", Hepatology, vol. 53, no. 1, pp. 209–218.
|
| [4] | S. Roy, G. J. Hooiveld, M. Seehawer, S. Caruso, F. Heinzmann, A. T. Schneider, A. K. Frank, D. V. Cardenas, R. Sonntag, M. Luedde, C. Trautwein, I. Stein, E. Pikarsky, S. Loosen, F. Tacke, M. Ringelhan, S. K. Avsaroglu, A. Goga, M. Buendia, M. Vucur, M. Heikenwalder, J. Zucman-Rossi, L. Zender, C. Roderburg, T. Luedde,
"microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis", Gastroenterology, vol. 155, no. 6, pp. 1951–1966.e26.
|
| [3] | A. T. Schneider, J. Gautheron, F. Tacke, M. Vucur, T. Luedde,
"Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity", Hepatology, vol. 64, no. 1, pp. 306–308.
|
| [2] | A. Schneider, J. Gautheron, M. Feoktistova, C. Roderburg, S. Loosen, P. Schemmer, M. Büchler, U. Neumann, F. Tacke, C. Trautwein, T. Longerich, M. Vucur, T. Luedde,
"RIPK1 suppresses a TRAF2-dependent pathway to liver cancer", J. Hepatol., vol. 66, no. 1, pp. S229.
|
| [1] | M. Vucur, F. Reisinger, J. Gautheron, J. Janssen, C. Roderburg, D. V. Cardenas, K. Kreggenwinkel, C. Koppe, L. Hammerich, R. Hakem, K. Unger, A. Weber, N. Gassler, M. Luedde, N. Frey, U. P. Neumann, F. Tacke, C. Trautwein, M. Heikenwalder, T. Luedde,
"RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell Proliferation", Cell Rep., vol. 4, no. 4, pp. 776–790.
|